Rock Creek Group’s IN8bio INAB Stock Holding History

Rock Creek Group’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Hold	0	–	–	–	45
2024 Q4	–	Sell	-1,010	Closed	-$8.87K	–	47
2024 Q3	$8.18K	Sell	1,010 -736	-42%	-$13.3K	﹤0.01%	45
2024 Q2	$44.3K	Sell	1,746 -3,298	-65%	-$106K	0.01%	57
2024 Q1	$209K	Hold	5,044	–	–	0.03%	45
2023 Q4	$209K	Hold	5,044	–	–	0.03%	38
2023 Q3	$157K	Buy	5,044 +2,500	+98%	+$93.8K	0.02%	95
2023 Q2	$118K	Sell	2,544 -175	-6%	-$10.9K	0.02%	118
2023 Q1	$106K	Hold	2,719	–	–	0.01%	121
2022 Q4	$188K	Buy	+2,719	New	+$152K	0.02%	89
2021 Q4	–	Sell	-1,409	Closed	-$292K	–	221
2021 Q3	$292K	Buy	+1,409	New	+$350K	0.05%	82

Other funds holding INAB

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIG

Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rock Creek Group's INAB Position: Q1 2025 in Review

Rock Creek Group held its IN8bio (INAB) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #45.

Rock Creek Group first reported a position in INAB in Q3 2021 and has held it in 9 quarters since. The position peaked at $292K in Q3 2021. 28 funds tracked by Wall St. Rank hold INAB as of Q1 2025.

Rock Creek Group held 0 shares of IN8bio worth $0 as of Q1 2025.
Rock Creek Group left its IN8bio share count unchanged in Q1 2025.
IN8bio made up ﹤0.01% of Rock Creek Group's portfolio in Q1 2025, its #45 holding.
Rock Creek Group first reported a position in IN8bio in Q3 2021 and has held it in 9 quarters since.
Rock Creek Group's IN8bio position peaked at $292K in Q3 2021.
28 funds tracked by Wall St. Rank held IN8bio as of Q1 2025.

Based on Rock Creek Group's 13F filing for Q1 2025, filed 13 May 2025.